TLR2 and central nervous system cancer: Glioma cells expressing Toll-like receptor 2 (TLR2) ligands (e.g., heat shock proteins and extracellular matrix components) trigger the activation of microglial TLR2 and signaling through MAPK/ERK, leading to the deacetylation of histone H3K9.